Robert O'Brien, RPh; Diana Brixner, PhD; Ashley Peterson, MHA; and Paul Jeffrey, PharmD, discuss the current state of prescription digital therapeutics (PDTs) adoption and explore strategies for increasing payer approval and widespread coverage of PDTs.
EP. 1: Differentiating PDTs from Wellness Apps and Evaluating Efficacy
May 15th 2024Diana Brixner, PhD, and Ashley Peterson, MHA, explore the distinctions between prescription digital therapeutics (PDTs) and wellness mobile apps, addressing the role of insurance coverage and the clinical validation requirements that payers consider when determining whether to cover PDTs as a treatment modality.
Watch
EP. 2: Payer Needs and Strategies for Evaluating and Covering PDTs
May 15th 2024Panelists delve into the data and the cost-saving evidence required by payers to cover prescription digital therapeutics (PDTs), outline the decision-making process followed by payers, and share best practices observed in real-world to ensure the successful implementation of PDTs.
Watch